Effects of gentamicin and gentamicin-RGD coatings on bone ingrowth and biocompatibility of cementless joint prostheses: An experimental study in rabbits

Acta Biomaterialia

Volumn 7, Issue 3, 2011, Pages 1274-1280

  Alt, Volker ^a   Bitschnau, Achim ^a   Böhner, Felicitas ^a   Heerich, Katharina Elisabeth ^a   Magesin, Erika ^a   Sewing, Andreas ^b   Pavlidis, Theodoros ^a   Szalay, Gabor ^a   Heiss, Christian ^a   Thormann, Ulrich ^a   Hartmann, Sonja ^c   Pabst, Wolfgang ^c   Wenisch, Sabine ^c   Schnettler, Reinhard ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b Biomet Deutschland GmbH   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Arthroplasty; Biocompatibility; Bone formation; Gentamicin; Hydroxyapatite

Indexed keywords

AMINO ACIDS; ANIMALS; BONE; COATINGS; HIP PROSTHESES; HYDROXYAPATITE; INTEGRATION; ORTHOPEDICS; STATISTICS;

BONE FORMATION; CEMENTLESS; GENTAMICIN; HA COATING; HIGH STANDARDS; IN-VITRO; IN-VIVO; MULTINUCLEATED GIANT CELLS; STANDARD DEVIATION; TIME POINTS;

ARTHROPLASTY;

ARGINYLGLYCYLASPARTIC ACID; GENTAMICIN; HYDROXYAPATITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BONE GROWTH; CONTROLLED STUDY; ELUTION; EXPERIMENTAL RABBIT; GIANT CELL; HISTOLOGY; JOINT PROSTHESIS; MATERIAL COATING; METAPHYSIS; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; TIBIA;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 79251619476     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2010.11.012     Document Type: Article

References (43)

1. L.B. Engesaeter, B. Espehaug, and S.A. Lie Does cement increase the risk of infection in primary total hip arthroplasty? Revision rates in 56,275 cemented and uncemented primary THAs followed for 0-16 years in the Norwegian Arthroplasty Register Acta Orthop Scand 77 2006 351 358
2. L.B. Engesaeter, S.A. Lie, and B. Espehaug Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register Acta Orthop Scand 74 2003 644 651
3. H.W. Buchholz, and H. Engelbrecht Über die depotwirkung einiger antibiotika bei vermischung mit dem kunstharz palacos Der Chirurg 40 1970 511 515
4. K. Klemm Gentamicin-PMMA-beads in treating bone and soft tissue infections Zentralbl Chir 104 14 1979 934 942 [in German]
5. V. Alt, A. Bitschnau, and J. Osterling The effects of combined gentamicin-hydroxyapatite coating for cementless joint prostheses on the reduction of infection rates in a rabbit infection prophylaxis model Biomaterials 26 2006 4627 4634
6. Y.H. An, J. Bradley, and D.L. Powers The prevention of prosthetic infection using a cross-linked albumin coating in a rabbit model J Bone Joint Surg Br 79 1997 816 819
7. V. Antoci Jr., S.B. King, and B. Jose Vancomycin covalently bonded to titanium alloy prevents bacterial colonization J Orthop Res 25 2007 858 866
8. A.A. Campbell, L. Song, and X.S. Li Development, characterization, and anti-microbial efficacy of hydroxyapatite chlorhexidine coatings produced by surface-induced mineralization J Biomed Mater Res 53 2000 400 407
9. R.O. Darouiche, M.D. Mansouri, and D. Zakarevicz In vivo efficacy of antimicrobial-coated devices J Bone Joint Surg Am 89 2007 792 797
10. E.S. De Jong, T.M. De Berardino, and D.E. Brooks Antimicrobial efficacy of external fixator pins coated with a lipid stabilized hydroxyapatite/ chlorhexidine complex to prevent pin tract infection in a goat model J Trauma 50 2001 1008 1014
11. D.S. Dunn, S. Raghavan, and R.G. Volz Gentamicin sulphate attachment and release from anodized Ti-6A1-4V orthopedic materials J Biomed Mater Res 27 1993 895 900
12. H. Gollwitzer, K. Ibrahim, and H. Meyer Antibacterial poly(d,l-lactic acid) coating of medical implants using a biodegradable drug delivery technology J Antimicrob Chemother 51 2003 585 591
13. T. Kälicke, J. Schierholz, and U. Schlegel Effect on infection resistance of a local antiseptic and antibiotic coating on osteosynthesis implants: an in vitro and in vivo study J Orthop Res 24 2006 1622 1640
14. M. Lucke, G. Schmidmaier, and S. Sadoni Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats Bone 32 2003 521 531
15. D.J. Moojen, H.C. Vogely, and A. Fleer Prophylaxis of infection and effects on osseointegration using a tobramycin-periapatite coating on titanium implants - an experimental study in the rabbit J Orthop Res 27 2009 1002 1007
16. J.S. Price, A.F. Tencer, and D.M. Arm Controlled release of antibiotics from coated orthopedic implants J Biomed Mater Res 30 1996 281 286
17. M. Stigter, K. de Groot, and P. Layrolle Incorporation of tobramycin into biomimetic hydroxyapatite coating on titanium Biomaterials 23 2002 4143 4153
18. M. Stigter, J. Bezemer, and K. de Groot Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy J Control Release 99 2004 127 137
19. L.I. Havelin, L.B. Engesaeter, and B. Espehaug The Norwegian Arthroplasty Register: 11 years and 73,000 arthroplasties Acta Orthop Scand 71 2000 337 353
20. C.J. Oosterbos, A.I. Rahmy, and A.J. Tonino High survival rate of hydroxyapatite-coated hip prostheses: 100 consecutive hips followed for 10 years Acta Orthop Scand 75 2004 127 133
21. R. Bernhardt, J. van den Dolder, and S. Bierbaum Osteoconductive modifications of Ti-implants in a goat defect model: characterization of bone growth with SR muCT and histology Biomaterials 26 2005 3009 3019
22. D.M. Ferris, G.D. Moodie, and P.M. Dimond RGD-coated titanium implants stimulate increased bone formation in vivo Biomaterials 20 1999 2323 2331
23. M. Kantlehner, P. Schaffner, and D. Finsinger Surface coating with cyclic RGD peptides stimulates osteoblast adhesion and proliferation as well as bone formation ChemBioChem 18 2000 107 114
24. M. Kantlehner, D. Finsinger, and J. Meyer Selective RGD-mediated adhesion of osteoblasts at surfaces of implants Angew Chem Int Ed 38 1999 560 562
25. B. Elmengaard, J.E. Bechtold, and K. Soballe In vivo effects of RGD-coated titanium implants inserted in two bone-gap models J Biomed Mater Res A 75 2005 249 255
26. B. Elmengaard, J.E. Bechtold, and K. Soballe In vivo study of the effect of RGD treatment on bone ongrowth on press-fit titanium alloy implants Biomaterials 26 2005 3521 3526
27. S. Rammelt, T. Illert, and S. Bierbaum Coating of titanium implants with collagen, RGD peptide and chondroitin sulfate Biomaterials 27 2006 5561 5571
28. A. Bitschnau, V. Alt, and F. Böhner Comparison of new bone formation, implant integration, and biocompatibility between RGD-hydroxyapatite and pure hydroxyapatite coating for cementless joint prostheses - an experimental study in rabbits J Biomed Mater Res B Appl Biomater 88 2009 66 74
29. N. Düwelhenke, O. Krut, and P. Eysel Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines Antimicrob Agents Chemother 51 2007 54 63
30. M.L. Edin, T. Miclau, and G.E. Lester Effect of cefazolin and vancomycin on osteoblasts in vitro Clin Orthop Relat Res 333 1996 245 251
31. S. Isefuku, C.J. Joyner, and A.H. Simpson Gentamicin may have an adverse effect on osteogenesis J Orthop Trauma 17 2003 212 216
32. T. Miclau, M.L. Edin, and G.E. Lester Bone toxicity of locally applied aminoglycosides J Orthop Trauma 9 1995 401 406
33. S. Rössler, A. Sewing, and M. Stolzel Electrochemically assisted deposition of thin calcium phosphate coatings at near-physiological pH and temperature J Biomed Mater Res A 64 2003 655 663
34. J. Auernheimer, D. Zukowski, and C. Dahmen Titanium implant materials with improved biocompatibility through coating with phosphonate-anchored cyclic RGD peptides ChemBioChem 6 2005 2034 2040
35. K. Donath, and G. Breuner A method for the study of undecalcified bones and teeth with attached soft tissues. The Sage-Schliff (sawing and grinding) technique J Oral Pathol 11 1982 318 326
36. M. Gottlander, C.B. Johansson, and T. Albrektsson Short- and long-term animal studies with a plasma-sprayed calcium phosphate-coated implant Clin Oral Implants Res 8 1997 345 351
37. S. Lundgren, T. Carling, and G. Hjalm Tissue distribution of human gp330/megalin, a putative Ca(2+)-sensing protein J Histochem Cytochem 45 1997 383 392
38. S.K. Moestrup, S. Cui, and H. Vorum Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs J Clin Invest 96 1995 1404 1413
39. C. Schmitz, J. Hilpert, and C. Jacobsen Megalin deficiency offers protection from renal aminoglycoside accumulation J Biol Chem 277 2002 618 622
40. F.J. Silverblatt, and C. Kuehn Autoradiography of gentamicin uptake by the rat proximal tubule cell Kidney Int 15 1979 335 345
41. P. Tulkens, and F. van Hoof Comparative toxicity of aminoglycoside antibiotics towards the lysosomes in a cell culture model Toxicology 17 1980 195 199
42. P.J. Davey, J.M. Haslam, and A.W. Linnane Biogenesis of mitochondria 12. The effects of aminoglycoside antibiotics on the mitochondrial and cytoplasmic protein-synthesizing systems of Saccharomyces cerevisiae Arch Biochem Biophys 136 1970 54 64
43. D.T. Ward, D. Maldonado-Perez, and L. Hollins Aminoglycosides induce acute cell signaling and chronic cell death in renal cells that express the calcium-sensing receptor J Am Soc Nephrol 16 2005 1236 1244